article thumbnail

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies

Alta Sciences

He began his career in academia, focusing on plant epigenetics and molecular biology in Paris, France. After completing his doctorate, he moved into the industry by joining a startup that specialized in enzymatic DNA synthesis, where he enhanced their processes and reagents using automated liquid handling technology.

article thumbnail

The inner workings of environmental bacterium

Drug Target Review

A team led by Professor Dr Ralf Rabus, a microbiologist at the University of Oldenburg, in collaboration with his doctoral student Patrick Becker, has achieved profound insights into the inner workings of a prevalent environmental bacterium.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

She received her Doctor of Philosophy in Biochemistry & Molecular Biology at the Graduate University of Chinese Academy of Sciences, Beijing, China, and a Master of Medicine in Toxicology at The Academy of Military Medical Sciences, Beijing, China.

article thumbnail

Automated red blood cell exchange: bridging treatment gaps in sickle cell disease care

Drug Target Review

Aaron Haubner, PhD, MBA is the Senior Manager, North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies Aaron earned his doctorate in pharmaceutical sciences and his MBA in finance.

Disease 52
article thumbnail

Precision Medicine – it’s not just for oncology anymore

The Pharma Data

In the past two decades we have learned so much in oncology about the molecular biology of cancer and that has led to better treatments for patients. By using these approaches, we hope to not only accelerate medicine development but also someday put these tools in the hands of patients and doctors to help guide treatment decisions.”.

article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

Our experts have over five years of experience with CRISPR gene-editing therapeutics in nonhuman primates (NHPs) and extensive expertise in bioanalysis for biodistribution studies, in addition to many molecular biology platforms , such as ligand binding assays (LBA), NAbs, TAbs, flow cytometry , and ELISpot.

article thumbnail

F. William Studier receives the 2024 Merkin Prize in ceremony at the Broad Institute for developing technology used to produce millions of doses of COVID-19 vaccines

Broad Institute

HPN develops and manages coordinated, patient-doctor centric, integrated health care systems that offer some of the strongest solutions for the future of health, care, and cost in the United States. He has a humble, self-effacing demeanor, and yet he is great at pushing people to make bold bets and to try to make the impossible possible."

Vaccine 64